Genprex, Inc. (GNPX)

NasdaqCM • Currently down 0.01 (-1.48%) in today's trading session

1 member of Congress has disclosed 4 trades in Genprex, Inc. (GNPX) via STOCK Act filings. The most recent disclosure was a purchase by Tim Moore on 5 February 2026. Aggregate disclosed activity totals roughly $56.5K in purchases (midpoint estimates from bracketed disclosure amounts).

Genprex, Inc. is currently trading at $0.85, positioned at 0% of its 52-week range ($0.81 – $55.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$0.85
24h Change
-0.01 (-1.48%)
52 Week Range
$0.81—$55.00
View on NASDAQ

Genprex, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GNPX

Select to highlight on chart
4 transactions
Compliance: 100%
Tim Moore5 Feb 202620 Feb 2026PurchaseStock$1,001 - $15,000-62.35%
Tim Moore18 Dec 20257 Jan 2026PurchaseStock$1,001 - $15,000-64.14%
Tim Moore7 Nov 20252 Dec 2025PurchaseStock$1,001 - $15,000-82.26%
Tim Moore29 Oct 202512 Nov 2025PurchaseStock$15,001 - $50,000-88.10%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.36M

Volume

44.44K

Beta

-0.93

P/E Ratio

-0.05

Fundamentals

EPS

$-17.40

Div. Yield

—

Open

$0.88

Day Range

$0.83 — $0.88

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Ryan Confer
IPO Date
2018-03-29
Website
www.genprex.com

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company i...

Earnings

Next Report

Q2 2026

2 Sept

EPS Est.

—

Rev. Est.

—

Days Until

110

Recent Quarters

Q1 202613 May
EPS$-0.64
Q4 202530 Mar
EPS$-1.15
Beat 91.2%
Q3 202514 Nov
EPS$-5.00
Beat 60.0%
Q2 202514 Aug
EPS$-8.50
Beat 59.5%
Q1 202512 May
EPS$-0.26
Beat 68.3%
Q1 20257 Apr
EPS$-1.15
Miss 40.2%
Q3 202413 Nov
EPS$-1.23
Miss 8.8%
Q2 20249 Aug
EPS$-3.00
Miss 30.4%
Q1 202415 May
EPS$-3.69
Miss 45.3%
Q4 202329 Mar
EPS$-3.96
Miss 0.8%
Q3 202314 Nov
EPS$-5.20
Miss 4627.3%
Q2 202321 Aug
EPS$-6.00
Miss 25.0%
Q1 202322 May
EPS$-7.60
Miss 58.3%
Q4 202231 Mar
EPS$-6.00
Miss 15.4%
Q3 202214 Nov
EPS$-5.20
Miss 4233.3%
Q2 202212 Aug
EPS$-4.40
Miss 10.0%
Q1 202213 May
EPS$-4.80
Miss 33.3%
Q4 202130 Mar
EPS$-4.80
Miss 5233.3%
Q3 202115 Nov
EPS$-2.80
Q2 202113 Aug
EPS$-3.20
Miss 2361.5%
Q1 202117 May
EPS$-5.60
Miss 4566.7%
Q4 202026 Mar
EPS$-5.60
Miss 1900.0%
Q3 202012 Nov
EPS$-2.80
Miss 1233.3%
Q2 202011 Aug
EPS$-4.80
Beat 36.8%
Q1 202014 May
EPS$-8.00
Miss 6566.7%
Q4 201930 Mar
EPS$-5.60
Q3 201914 Nov
EPS$-6.00
Beat 31.8%
Q2 201913 Aug
EPS$-9.60
Miss 14.3%
Q1 201915 May
EPS$-5.60
Beat 39.1%
Q1 20191 Apr
EPS$-9.20
Miss 27.8%
Q3 201814 Nov
EPS$-0.15
Miss 15.4%
Q2 201814 Aug
EPS$-17.95
Q1 201815 May
EPS$-2.36
Q4 201729 Mar
EPS$-2.32
Q3 201727 Nov
EPS$-2.46
Q1 201730 Jun
EPS$-4.12
Q4 201631 Mar
EPS$-2.64
Q3 201631 Dec
EPS$-6.16
Q2 201630 Sept
EPS$-13.45
Q1 201630 Jun
EPS$-38.55
Q4 201531 Mar
EPS$-6.33

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

21 Oct 2025Reverse Split
Ratio1:50
2 Feb 2024Reverse Split
Ratio1:40

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CNC

Centene Corporation

47
$58.78+0.08 (+0.14%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

TNA

Direxion Daily Small Cap Bull 3X Shares

22
$61.57-3.62 (-5.55%)
Financial Services
Held by same politician
Significant holdings value
1 politician
View Stock

LGIH

LGI Homes, Inc.

17
$41.94-1.78 (-4.07%)
Consumer Cyclical
Held by same politician
1 politician
View Stock

Frequently Asked Questions about GNPX

Which members of Congress have traded GNPX?
1 member of Congress has disclosed 4 trade in Genprex, Inc. (GNPX) under the STOCK Act: Tim Moore.
When was GNPX most recently disclosed by Congress?
The most recent GNPX disclosure was a purchase by Tim Moore on 5 February 2026.
What is the total disclosed congressional trading volume for GNPX?
Members of Congress have disclosed approximately $56.5K in GNPX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in GNPX?
This GNPX page updates as soon as new STOCK Act disclosures are filed for Genprex, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.